It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Ethics Board Approval Granted for Lexaria Receives Ethics Board Approval for 12-Week Phase 1b DehydraTECH GLP-1 Study in ...

The Company is also announcing that clinical test article manufacturing for all planned Study arms has already been completed. This includes production for the four planned DehydraTECH formulation ...

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global i ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Rybelsus: Novo Nordisk’s name-brand version of oral semaglutide tablets to help improve blood sugar levels (along with diet ...

Of these, injections such as Wegovy have dominated headlines. But that might be about to change. A tablet oral formulation of semaglutide (the active ingredient in Wegovy and the Type 2 diabetes ...

Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.

The results showed that both the oral insulin tablet and injectable Lantus substantially ... its next-generation GLP-1 analogue semaglutide is set for filing as an injectable this year, but ...

Did you know over eight million Nigerians are living with diabetes? Click and discover Inside Nigeria’s diabetes crisis: Lifestyle and more ...

A source tells Android Authority that Google is working on the Pixel Tablet 2 and that this time the company might release a keyboard case. We were also told the Pixel Tablet 2 will have a new ...